Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients.

Huang Y, Cheng G, Liu B, Shao P, Qin C, Li J, Hua L, Yin C.

BMC Urol. 2014 Jan 11;14:8. doi: 10.1186/1471-2490-14-8.

2.

Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsies.

Zhao R, Huang Y, Cheng G, Liu J, Shao P, Qin C, Hua L, Yin C.

PLoS One. 2014 Sep 30;9(9):e106933. doi: 10.1371/journal.pone.0106933. eCollection 2014.

3.

The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.

Tanaka N, Shimada K, Nakagawa Y, Hirao S, Watanabe S, Miyake M, Anai S, Hirayama A, Konishi N, Fujimoto K.

BMC Res Notes. 2015 Nov 18;8:689. doi: 10.1186/s13104-015-1668-9.

4.

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.

Suzuki H, Komiya A, Kamiya N, Imamoto T, Kawamura K, Miura J, Suzuki N, Nakatsu H, Hata A, Ichikawa T.

Urology. 2006 Jan;67(1):131-6.

PMID:
16413348
5.

Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.

Li X, Pan Y, Huang Y, Wang J, Zhang C, Wu J, Cheng G, Qin C, Hua L, Wang Z.

Int Urol Nephrol. 2016 Apr;48(4):535-40. doi: 10.1007/s11255-016-1218-y. Epub 2016 Jan 25.

PMID:
26810323
6.

Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.

Nicolaiew N, Ploussard G, Chun FK, Xylinas E, Allory Y, Salomon L, de la Taille A.

Urol Int. 2013;90(3):306-11. doi: 10.1159/000345603. Epub 2013 Jan 5.

PMID:
23295308
7.

Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.

Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.

Int J Urol. 2008 Jul;15(7):598-603. doi: 10.1111/j.1442-2042.2008.02058.x. Epub 2008 May 2.

8.

A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.

Nakanishi H, Wang X, Ochiai A, Trpkov K, Yilmaz A, Donnelly JB, Davis JW, Troncoso P, Babaian RJ.

Cancer. 2007 Dec 1;110(11):2441-7.

9.

Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.

Kuo SC, Hung SH, Wang HY, Chien CC, Lu CL, Lin HJ, Guo HR, Zou JF, Lin CS, Huang CC.

Asian J Androl. 2013 Nov;15(6):780-4. doi: 10.1038/aja.2013.100. Epub 2013 Oct 14.

10.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.

11.

A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.

Tang P, Chen H, Uhlman M, Lin YR, Deng XR, Wang B, Yang WJ, Xie KJ.

Asian J Androl. 2013 Jan;15(1):129-33. doi: 10.1038/aja.2012.111. Epub 2012 Dec 10.

12.
13.

Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.

Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, Pummer K, Graefen M, Haese A, Walz J, Briganti A, Shariat SF, Chun FK.

Eur Urol. 2013 Feb;63(2):201-9. doi: 10.1016/j.eururo.2012.07.030. Epub 2012 Jul 20.

PMID:
22854248
14.

A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.

Lee A, Lim J, Gao X, Liu L, Chia SJ.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e348-e355. doi: 10.1111/ajco.12596. Epub 2016 Sep 19.

PMID:
27641069
15.

The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.

Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B.

J Urol. 2005 Oct;174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261.

PMID:
16145388
16.

Developing a Correct System to Evaluate the Accuracy of Gleason Score in Prostate Cancer of Chinese Population.

Wang J, Cheng G, Li X, Huang Y, Pan Y, Qin C, Hua L, Wang Z.

Urol Int. 2016;96(3):295-301. doi: 10.1159/000443408. Epub 2016 Feb 5.

PMID:
26849662
17.

[Prospective validation of a nomogram predictive of a positive initial prostate biopsy].

Ramírez-Backhaus M, Bahilo P, Arlandis S, Santamaría Navarro C, Pontones Moreno JL, Jiménez-Cruz F.

Actas Urol Esp. 2010 Jan;34(1):35-42. Spanish.

PMID:
20223131
18.

Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.

Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Loblaw A, Pond GR, Emami M, Sugar L, Sweet J, Narod SA.

Can J Urol. 2006 Apr;13 Suppl 2:2-10.

PMID:
16672122
19.

Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.

Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW.

Urology. 2003 Mar;61(3):589-95.

PMID:
12639653
20.

[Establishment of a nomogram for predicting positive repeat prostate biopsy in Chinese men].

Li QY, Tang J, Li YM, Fei X, Zhang Y, He EH, Zhou Y.

Zhonghua Nan Ke Xue. 2012 Apr;18(4):302-5. Chinese.

PMID:
22574362

Supplemental Content

Support Center